Published on 6 May 2024 on Zacks via Yahoo Finance
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.73 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -7.27%. A quarter ago, it was expected that this company would post a loss of $0.79 per share when it actually produced a loss of $0.57, delivering a surprise of 27.85%.